Ignite Creation Date:
2025-12-24 @ 11:58 AM
Ignite Modification Date:
2025-12-29 @ 8:32 PM
Study NCT ID:
NCT00935961
Status:
COMPLETED
Last Update Posted:
2013-08-09
First Post:
2009-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center